AHCO AdaptHealth Corp.companySEC Filings & Insider Trading Activity 2026
Latest AdaptHealth Corp. (AHCO) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 24, 2026, a 10-Q quarterly report filed on November 4, 2025, an 8-K current report filed on April 13, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for AdaptHealth Corp. (AHCO) (SEC CIK 1725255), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business: Patient-centered healthcare-at-home solutions, including home medical equipment, medical supplies, and related services across four segments (Sleep, Respiratory, Diabetes, Wellness)
- • Newly emphasized: Deployment of artificial intelligence (AI), including generative AI, for improving patient and operational workflows with associated regulatory risks highlighted
Risk Factors
- • Regulatory risk: 2026 CMS Final Rule bundling payment for CGMs and insulin pumps starting January 1, 2028, may disrupt AdaptHealth's product coverage and reimbursement
- • Macroeconomic risk: Inflation and rising interest rates could increase costs and interest expense on variable rate debt, impairing refinancing and cash flow
Management Discussion & Analysis
- • Net revenue $3.24B in 2025, down 0.5% YoY from $3.26B in 2024, driven by $56.9M organic growth offset by $92.4M disposition decline
- • Operating margin 2.8% in 2025 vs 8.1% in 2024; net loss $(70.8M) vs net income $90.4M; goodwill impairment $128M in 2025 vs $13.1M prior year
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Risk Factors
- • New regulatory risk: Section 232 Commerce investigation on imports of medical equipment initiated September 2, 2025, may trigger tariffs impacting AdaptHealth
- • Most updated operational risk: October 1, 2025 federal government shutdown potentially delaying Medicare and Medicaid payments
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year fiscal 2025 earnings released Feb 24, 2026; period ending Dec 31, 2025
- • Full financial results in Exhibit 99.1 — press release contains key metrics and management commentary
Annual Reports Archive10-K
AI-powered analysis of AdaptHealth Corp. (AHCO) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of AdaptHealth Corp. (AHCO) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of AdaptHealth Corp. (AHCO) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $3.0B | $3.2B | $3.3B | $3.2B |
| Operating Income | $190.4M | -$598.4M | $263.7M | $90.9M |
| Net Income | $69.3M | -$678.9M | $90.4M | -$70.8M |
| Op. Margin | 6.4% | -18.7% | 8.1% | 2.8% |
| Net Margin | 2.3% | -21.2% | 2.8% | -2.2% |
| Balance Sheet | ||||
| Total Assets | $5.2B | $4.5B | $4.5B | $4.3B |
| Equity | $2.2B | $1.5B | $1.6B | $1.5B |
| ROE | 3.2% | -46.5% | 5.8% | -4.7% |
Source: XBRL financial data from AdaptHealth Corp. (AHCO) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 13, 2026 | — | — | — |
8-K | Feb 24, 2026 | — | Analysis | — |
10-K | Feb 24, 2026 | Dec 31, 2025 | Analysis | |
10-Q | Nov 4, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 5, 2025 | Jun 30, 2025 | — | |
10-Q | May 6, 2025 | Mar 31, 2025 | — | |
10-K | Feb 25, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 5, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 6, 2024 | Jun 30, 2024 | — | |
10-Q | May 7, 2024 | Mar 31, 2024 | — | |
10-K | Feb 27, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 7, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 8, 2023 | Jun 30, 2023 | — | |
10-Q | May 9, 2023 | Mar 31, 2023 | — | |
10-K | Feb 28, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 8, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 9, 2022 | Jun 30, 2022 | — | |
10-Q | May 10, 2022 | Mar 31, 2022 | — | |
10-K | Mar 1, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 9, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 6, 2021 | Jun 30, 2021 | — | |
10-Q | May 10, 2021 | Mar 31, 2021 | — | |
10-Q | Nov 6, 2020 | Sep 30, 2020 | — | |
10-Q | Aug 7, 2020 | Jun 30, 2020 | — | |
10-Q | May 8, 2020 | Mar 31, 2020 | — |
Frequently Asked Questions
What are the latest AHCO SEC filings in 2026?
AdaptHealth Corp. (AHCO) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 4, 2025, an 8-K current report on April 13, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did AHCO file its most recent 10-K annual report?
AdaptHealth Corp. (AHCO) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view AHCO 10-Q quarterly reports?
AdaptHealth Corp. (AHCO)'s most recent 10-Q quarterly report was filed on November 4, 2025. SignalX displays every AHCO 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has AHCO filed recently?
AdaptHealth Corp. (AHCO)'s most recent 8-K was filed on April 13, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find AHCO insider trading activity (Form 4)?
SignalX aggregates every AHCO Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does AHCO file with the SEC?
AdaptHealth Corp. (AHCO) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new AHCO filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for AdaptHealth Corp. (AHCO).
What is AHCO's SEC CIK number?
AdaptHealth Corp. (AHCO)'s SEC CIK (Central Index Key) number is 1725255. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1725255 to look up all AHCO filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find AHCO return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from AdaptHealth Corp. (AHCO) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of AdaptHealth Corp. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 33+ filings.